XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Series C Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Series C Cumulative Redeemable Preferred Stock
Series C Cumulative Redeemable Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series C Preferred Stock
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest - Units in the Operating Partnership
Non-controlling Interest - Members in Consolidated Real Estate Entities
Beginning balance at Dec. 31, 2018 $ 3,830,130   $ (2,105)     $ 1,543 $ 3,524,502   $ 0 $ (2,105) $ 17,501 $ 18,338 $ 268,246
Beginning balance (in shares) at Dec. 31, 2018           154,371,538              
Increase (Decrease) in Stockholders' Equity                          
Distributions (12,111)                       (12,111)
Issuance of unrestricted stock 0         $ 5 (5)            
Issuance of unrestricted stock (in shares)           554,237              
Shares withheld to satisfy tax withholding obligations $ (7,684)         $ (2) (7,682)            
Shares withheld to satisfy tax withholding (in shares)           (234,723)              
Repurchase of common stock (in shares) 0                        
Declared dividend $ (157,825)           (114,283)   (41,312)     (2,230)  
Amortization of stock-based compensation 20,432           13,276         7,156  
Net income 57,228               43,417     459 13,352
Other comprehensive income (loss) (18,178)                   (18,062) (116)  
Redemption of common units in the operating partnership (525)           0       0 (525)  
Ending balance at Dec. 31, 2019 3,709,362         $ 1,546 3,415,808   0   (561) 23,082 269,487
Ending balance (in shares) at Dec. 31, 2019           154,691,052              
Increase (Decrease) in Stockholders' Equity                          
Contributions 138,124                       138,124
Sale of non-controlling interest 367,142           300,104           67,038
Distributions (26,595)                       (26,595)
Transaction costs (16,047)           (16,047)            
Issuance of unrestricted stock 0         $ 5 (5)            
Issuance of unrestricted stock (in shares)           420,970              
Shares withheld to satisfy tax withholding obligations (7,582)         $ (2) (7,580)            
Shares withheld to satisfy tax withholding (in shares)           (225,314)              
Repurchase of common stock $ (80,213)         $ (35) (80,178)            
Repurchase of common stock (in shares) (3,500,000)         (3,485,343)              
Declared dividend $ (154,996)           (151,772)   (1,424)     (1,800)  
Amortization of stock-based compensation 26,029           9,428         16,601  
Net income 20,389               1,424     10 18,955
Other comprehensive income (loss) (7,633)                   (7,572) (61)  
Ending balance at Dec. 31, 2020 $ 3,967,980         $ 1,514 3,469,758   0   (8,133) 37,832 467,009
Ending balance (in shares) at Dec. 31, 2020 151,401,365         151,401,365              
Increase (Decrease) in Stockholders' Equity                          
Contributions $ 24,718                       24,718
Distributions (110,562)                       (110,562)
Proceeds from sale of stock, net of underwriters discount and transaction costs 44,820 $ 413,007     $ 425,000 $ 15 44,805 $ (11,993)          
Proceeds from sale of stock, net of underwriters’ discount and transaction costs (in shares)           1,526,163              
Transaction costs (243)           (243)            
Issuance of unrestricted stock 0         $ 2 (2)            
Issuance of unrestricted stock (in shares)           222,781              
Shares withheld to satisfy tax withholding obligations (2,206)         $ (1) (2,205)            
Shares withheld to satisfy tax withholding (in shares)           (90,843)              
Repurchase of common stock $ (46,137)         $ (19) (46,118)            
Repurchase of common stock (in shares) (1,900,000)         (1,934,923)              
Declared dividend $ (156,841)     $ (2,281)     (145,158)   (7,154)     (2,248)  
Amortization of stock-based compensation 24,687           8,228         16,459  
Net income 31,302     2,281         7,154     61 21,806
Other comprehensive income (loss) 6,467                   6,372 95  
Ending balance at Dec. 31, 2021 $ 4,196,992     $ 425,000   $ 1,511 $ 3,317,072   $ 0   $ (1,761) $ 52,199 $ 402,971
Ending balance (in shares) at Dec. 31, 2021 151,124,543         151,124,543